Bioptik Technology Incorporation (BIOPTIK TECH INC) aktie
4161.TWO
BIOPTIK TECH INC
Market Cap
$1,381,569,536
Om Bioptik Technology Incorporation (BIOPTIK TECH INC) aktie
Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. The company offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch, a glucose monitoring system for dogs and cats. It also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, cream/lotion, make-up removal, shampoo, time capsule, and toner/essence; and skin care products. In addition, the company is involved in manufacturing feed, canned food, and food additive, aircraft and parts, and chemicals; wholesale and import and export trade of cosmetics raw materials, semi-finished products and finished products; cosmetics retail and wholesale; and special forestry management. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.
Selskabsinformation
35057 Zhunan, Taiwan
Analytikernes aktieanbefalinger
Denne oversigt giver et hurtigt indblik i, hvordan analytikere vurderer aktiens potentiale baseret på deres seneste analyser og kursmål.